ميلبيرون (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "ميلبيرون" in Arabic language version.

refsWebsite

Global rank Arabic rank

19nih.gov

4^th place

6^th place

15doi.org

2^nd place

5^th place

2archive.org

6^th place

3^rd place

1ncats.io

low place

3,760^th place

1wikidata.org

43^rd place

2^nd place

1web.archive.org

1^st place

1medicinescomplete.com

low place

4,551^st place

archive.org

Borgström، L؛ Larsson, H؛ Molander, L (1982). "Pharmacokinetics of parenteral and oral melperone in man". European Journal of Clinical Pharmacology. ج. 23 ع. 2: 173–176. DOI:10.1007/BF00545974. PMID:7140807.
Molander، L؛ Birkhed, D (1981). "Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects". Psychopharmacology. ج. 75 ع. 2: 114–118. DOI:10.1007/bf00432171. PMID:6119724.

doi.org

Borgström، L؛ Larsson, H؛ Molander, L (1982). "Pharmacokinetics of parenteral and oral melperone in man". European Journal of Clinical Pharmacology. ج. 23 ع. 2: 173–176. DOI:10.1007/BF00545974. PMID:7140807.
Röhricht، F؛ Gadhia, S؛ Alam, R؛ Willis, M (2012). "Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia". Scientific World Journal. ج. 2012: 1–5. DOI:10.1100/2012/512047. PMC:3330679. PMID:22566771.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Whiskey، E؛ Vavrova, M؛ Gaughran, F؛ Taylor, D (فبراير 2011). "Melperone in Treatment-Refractory Schizophrenia: A Case Series". Therapeutic Advances in Psychopharmacology. ج. 1 ع. 1: 19–23. DOI:10.1177/2045125311399800. PMC:3736899. PMID:23983923.
Meltzer، HY؛ Sumiyoshi, T؛ Jayathilake, K (ديسمبر 2001). "Melperone in the treatment of neuroleptic-resistant schizophrenia". Psychiatry Research. ج. 105 ع. 3: 201–209. DOI:10.1016/s0165-1781(01)00346-8. PMID:11814539.
Sumiyoshi، T؛ Meltzer, HY؛ Jayathilake, K (2004). "Melperone, an atypical antipsychotic drug, in the treatment of schizophrenia: dose-response analysis on effectiveness and tolerability, and efficacy for treatment-resistant schizophrenia and cognitive function". International Clinical Psychopharmacology. ج. 19 ع. 3: 184. DOI:10.1097/00004850-200405000-00039.
Friedman، JH (مايو 2012). "Melperone is ineffective in treating Parkinson's disease psychosis". Movement Disorders. ج. 27 ع. 6: 803–804. DOI:10.1002/mds.24942. PMID:22362330.
Pöldinger، WJ (1984). "Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study". Neuropsychobiology. ج. 11 ع. 3: 181–186. DOI:10.1159/000118074. PMID:6147789.
Bobo، WV؛ Jayathilake, K؛ Lee, MA؛ Meltzer HY (أبريل 2010). "Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics". Psychiatry Research. ج. 176 ع. 2–3: 114–119. DOI:10.1016/j.psychres.2009.03.026. PMID:20199813.
Bobo، WV؛ Jayathilake, K؛ Lee, MA؛ Meltzer, HY (يوليو 2009). "Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics". Human Psychopharmacology: Clinical and Experimental. ج. 24 ع. 5: 415–422. DOI:10.1002/hup.1036. PMID:19551763.
Molander، L؛ Borgström, L (1983). "Sedative effects and prolactin response to single oral doses of melperone". Psychopharmacology. ج. 79 ع. 2–3: 142–147. DOI:10.1007/bf00427801. PMID:6133301.
Bjerkenstedt، L (1989). "Melperone in the treatment of schizophrenia". Acta Psychiatrica Scandinavica Supplementum. ج. 352: 35–39. DOI:10.1111/j.1600-0447.1989.tb06434.x. PMID:2479227.
Molander، L؛ Birkhed, D (1981). "Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects". Psychopharmacology. ج. 75 ع. 2: 114–118. DOI:10.1007/bf00432171. PMID:6119724.
Gahr، M؛ Gastl, R؛ Kölle, MA؛ Schönfeldt-Lecuona, C؛ Freudenmann, RW (2012). "Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report". Journal of Medical Case Reports. ج. 6 ع. 1: 49. DOI:10.1186/1752-1947-6-49. PMC:3298719. PMID:22309430.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Köhnke، MD؛ Lutz, U؛ Wiatr, G؛ Schwärzler, F؛ Weller, B؛ Schott, K؛ Buchkremer, G (أبريل 2006). "Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone". European Journal of Clinical Pharmacology. ج. 62 ع. 4: 333–334. DOI:10.1007/s00228-006-0098-y. PMID:16534635.
Grözinger، M؛ Dragicevic, A؛ Hiemke, C؛ Shams, M؛ Müller, MJ؛ Härtter, S (يناير 2003). "Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine". Pharmacopsychiatry. ج. 36 ع. 1: 3–6. DOI:10.1055/s-2003-38084. PMID:12649767.

medicinescomplete.com

about.medicinescomplete.com

Melperone Hydrochloride. The Royal Pharmaceutical Society of Great Britain. 30 يناير 2013. مؤرشف من الأصل في 2020-03-12. اطلع عليه بتاريخ 2013-11-03. {{استشهاد بكتاب}}: |عمل= تُجوهل (مساعدة)

ncats.io

drugs.ncats.io

Inxight: Drugs Database، QID:Q57664317

nih.gov

pubmed.ncbi.nlm.nih.gov

Borgström، L؛ Larsson, H؛ Molander, L (1982). "Pharmacokinetics of parenteral and oral melperone in man". European Journal of Clinical Pharmacology. ج. 23 ع. 2: 173–176. DOI:10.1007/BF00545974. PMID:7140807.
Röhricht، F؛ Gadhia, S؛ Alam, R؛ Willis, M (2012). "Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia". Scientific World Journal. ج. 2012: 1–5. DOI:10.1100/2012/512047. PMC:3330679. PMID:22566771.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Whiskey، E؛ Vavrova, M؛ Gaughran, F؛ Taylor, D (فبراير 2011). "Melperone in Treatment-Refractory Schizophrenia: A Case Series". Therapeutic Advances in Psychopharmacology. ج. 1 ع. 1: 19–23. DOI:10.1177/2045125311399800. PMC:3736899. PMID:23983923.
Meltzer، HY؛ Sumiyoshi, T؛ Jayathilake, K (ديسمبر 2001). "Melperone in the treatment of neuroleptic-resistant schizophrenia". Psychiatry Research. ج. 105 ع. 3: 201–209. DOI:10.1016/s0165-1781(01)00346-8. PMID:11814539.
Friedman، JH (مايو 2012). "Melperone is ineffective in treating Parkinson's disease psychosis". Movement Disorders. ج. 27 ع. 6: 803–804. DOI:10.1002/mds.24942. PMID:22362330.
Pöldinger، WJ (1984). "Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study". Neuropsychobiology. ج. 11 ع. 3: 181–186. DOI:10.1159/000118074. PMID:6147789.
Bobo، WV؛ Jayathilake, K؛ Lee, MA؛ Meltzer HY (أبريل 2010). "Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics". Psychiatry Research. ج. 176 ع. 2–3: 114–119. DOI:10.1016/j.psychres.2009.03.026. PMID:20199813.
Bobo، WV؛ Jayathilake, K؛ Lee, MA؛ Meltzer, HY (يوليو 2009). "Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics". Human Psychopharmacology: Clinical and Experimental. ج. 24 ع. 5: 415–422. DOI:10.1002/hup.1036. PMID:19551763.
Molander، L؛ Borgström, L (1983). "Sedative effects and prolactin response to single oral doses of melperone". Psychopharmacology. ج. 79 ع. 2–3: 142–147. DOI:10.1007/bf00427801. PMID:6133301.
Bjerkenstedt، L (1989). "Melperone in the treatment of schizophrenia". Acta Psychiatrica Scandinavica Supplementum. ج. 352: 35–39. DOI:10.1111/j.1600-0447.1989.tb06434.x. PMID:2479227.
Molander، L؛ Birkhed, D (1981). "Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects". Psychopharmacology. ج. 75 ع. 2: 114–118. DOI:10.1007/bf00432171. PMID:6119724.
Kirkegaard، A؛ Kirkegaard, G؛ Geismar, L (1981). "Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients". Arzneimittel-Forschung. ج. 31 ع. 4: 737–740. PMID:6113835.
Christensen، I؛ Geismar, L؛ Kirkegaard, A؛ Kirkegaard, G (مايو 1986). "Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients". Arzneimittel-Forschung. ج. 36 ع. 5: 855–860. PMID:2873821.
Gahr، M؛ Gastl, R؛ Kölle, MA؛ Schönfeldt-Lecuona, C؛ Freudenmann, RW (2012). "Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report". Journal of Medical Case Reports. ج. 6 ع. 1: 49. DOI:10.1186/1752-1947-6-49. PMC:3298719. PMID:22309430.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Köhnke، MD؛ Lutz, U؛ Wiatr, G؛ Schwärzler, F؛ Weller, B؛ Schott, K؛ Buchkremer, G (أبريل 2006). "Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone". European Journal of Clinical Pharmacology. ج. 62 ع. 4: 333–334. DOI:10.1007/s00228-006-0098-y. PMID:16534635.
Grözinger، M؛ Dragicevic, A؛ Hiemke, C؛ Shams, M؛ Müller, MJ؛ Härtter, S (يناير 2003). "Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine". Pharmacopsychiatry. ج. 36 ع. 1: 3–6. DOI:10.1055/s-2003-38084. PMID:12649767.

ncbi.nlm.nih.gov

Röhricht، F؛ Gadhia, S؛ Alam, R؛ Willis, M (2012). "Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia". Scientific World Journal. ج. 2012: 1–5. DOI:10.1100/2012/512047. PMC:3330679. PMID:22566771.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Whiskey، E؛ Vavrova, M؛ Gaughran, F؛ Taylor, D (فبراير 2011). "Melperone in Treatment-Refractory Schizophrenia: A Case Series". Therapeutic Advances in Psychopharmacology. ج. 1 ع. 1: 19–23. DOI:10.1177/2045125311399800. PMC:3736899. PMID:23983923.
Gahr، M؛ Gastl, R؛ Kölle, MA؛ Schönfeldt-Lecuona, C؛ Freudenmann, RW (2012). "Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report". Journal of Medical Case Reports. ج. 6 ع. 1: 49. DOI:10.1186/1752-1947-6-49. PMC:3298719. PMID:22309430.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)

web.archive.org

Melperone Hydrochloride. The Royal Pharmaceutical Society of Great Britain. 30 يناير 2013. مؤرشف من الأصل في 2020-03-12. اطلع عليه بتاريخ 2013-11-03. {{استشهاد بكتاب}}: |عمل= تُجوهل (مساعدة)

wikidata.org

Inxight: Drugs Database، QID:Q57664317